Share Price and Basic Stock Data
Last Updated: October 12, 2025, 12:38 am
| PEG Ratio | 0.86 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
DRA Consultants Ltd operates in the project consultancy and turnkey sector, with its shares currently priced at ₹21.5 and a market capitalization of ₹23.6 Cr. The company has shown fluctuating revenue trends over the past few years. Sales for the trailing twelve months stood at ₹14.98 Cr for FY 2023, recovering from a low of ₹14.96 Cr in FY 2021. The revenue saw an increase to ₹19.07 Cr in FY 2024 and is expected to reach ₹21.46 Cr in FY 2025. Quarterly sales figures also reflect variability, with Q2 FY 2023 recording ₹6.89 Cr, while Q1 FY 2025 reported a notable rise to ₹12.74 Cr. These trends indicate the company’s ability to adapt to market demands, although the operational environment remains challenging. The operating profit margin (OPM) has shown resilience, standing at 18.15% for FY 2025, which aligns closely with the industry average, suggesting effective cost management amid fluctuating sales. Overall, DRA’s revenue trajectory illustrates a gradual recovery and growth potential in the consultancy sector.
Profitability and Efficiency Metrics
DRA Consultants has demonstrated solid profitability metrics, with a net profit of ₹2.69 Cr for FY 2025, up from ₹2.38 Cr in FY 2024. The company’s net profit margin stands at 12.54%, indicating a healthy retention of earnings relative to sales. The return on equity (ROE) is reported at 8.07%, while return on capital employed (ROCE) is at 11.7%, both of which are satisfactory compared to industry benchmarks. The interest coverage ratio (ICR) is particularly strong at 17.70x, suggesting that the company comfortably covers its interest obligations, which is impressive given its zero borrowings. However, the cash conversion cycle (CCC) has been on the higher side at 145.41 days as of FY 2025, indicating potential inefficiencies in working capital management. This metric warrants attention as it may impact liquidity and operational agility in capitalizing on growth opportunities. Overall, DRA’s profitability and efficiency metrics present a commendable picture, albeit with room for improvement in working capital management.
Balance Sheet Strength and Financial Ratios
DRA Consultants’ balance sheet reflects a robust financial position, with total assets reported at ₹35.71 Cr and no outstanding borrowings, resulting in a debt-to-equity ratio of zero. The company’s reserves have grown significantly, reaching ₹21.85 Cr in FY 2025, which provides a cushion for future investments and operational flexibility. The current ratio stands at an impressive 5.98, indicating excellent short-term liquidity, while the quick ratio is similarly strong at 5.98, suggesting that the company can meet its short-term liabilities without relying on inventory. The price-to-book value (P/BV) ratio is reported at 0.83x, indicating the stock is trading below its book value, which may be attractive to value investors. Furthermore, the earnings yield is at 9%, which could be seen as favorable compared to typical equity returns in the sector. Overall, DRA’s balance sheet strength and financial ratios suggest a solid foundation for future growth, with minimal financial risk from debt.
Shareholding Pattern and Investor Confidence
The shareholding pattern of DRA Consultants reveals a stable ownership structure, with promoters holding 73.02% of the company, ensuring significant control and alignment with long-term strategic goals. The public holds the remaining 26.98%, with a total of 414 shareholders as of March 2025, reflecting a steady increase from previous periods. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may indicate a lack of institutional interest, which could be a concern for the company’s liquidity and market perception. However, the consistent promoter holding is a positive sign, as it suggests confidence in the company’s long-term prospects. The gradual increase in shareholder numbers also points to growing interest among retail investors, which can enhance liquidity. Nonetheless, the company must work on attracting institutional investors to bolster its market credibility and support future capital-raising efforts.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies improve, DRA Consultants could leverage its strong balance sheet and profitability metrics to expand its market share in the consultancy sector. However, the risks associated with a high cash conversion cycle and the absence of institutional backing could hinder growth. Additionally, fluctuating revenue trends may impact investor sentiment and operational planning. If the company can effectively manage its working capital and attract institutional investments, it may enhance its competitive positioning. The projected increase in sales and profitability indicates potential for future growth, but the company must remain vigilant regarding market conditions and operational challenges. Overall, DRA Consultants presents a cautiously optimistic scenario, with strengths in financial stability and profitability, yet requires attention to certain operational risks to fully realize its growth potential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of DRA Consultants Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fine Line Circuits Ltd | 47.8 Cr. | 99.3 | 115/52.4 | 265 | 18.4 | 0.00 % | 4.45 % | 2.30 % | 10.0 |
| Filtra Consultants & Engineers Ltd | 82.2 Cr. | 75.0 | 91.0/53.0 | 30.1 | 22.0 | 2.67 % | 16.5 % | 11.4 % | 10.0 |
| DRA Consultants Ltd | 23.6 Cr. | 21.5 | 47.5/18.0 | 9.29 | 29.9 | 0.00 % | 11.7 % | 8.07 % | 10.0 |
| Zodiac Energy Ltd | 573 Cr. | 379 | 620/318 | 28.2 | 64.0 | 0.20 % | 20.0 % | 27.5 % | 10.0 |
| Rites Ltd | 12,118 Cr. | 252 | 319/192 | 31.4 | 54.9 | 2.99 % | 21.8 % | 14.7 % | 10.0 |
| Industry Average | 3,320.57 Cr | 442.62 | 63.42 | 94.15 | 0.57% | 12.10% | 10.72% | 10.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.89 | 11.55 | 5.35 | 9.80 | 4.78 | 10.35 | 7.03 | 8.01 | 6.89 | 12.74 | 9.12 | 12.34 |
| Expenses | 6.97 | 11.26 | 5.05 | 7.80 | 4.16 | 8.34 | 5.64 | 6.83 | 5.65 | 10.59 | 7.42 | 10.10 |
| Operating Profit | 1.92 | 0.29 | 0.30 | 2.00 | 0.62 | 2.01 | 1.39 | 1.18 | 1.24 | 2.15 | 1.70 | 2.24 |
| OPM % | 21.60% | 2.51% | 5.61% | 20.41% | 12.97% | 19.42% | 19.77% | 14.73% | 18.00% | 16.88% | 18.64% | 18.15% |
| Other Income | 0.01 | 0.56 | 0.30 | 0.36 | 0.17 | 0.30 | 0.04 | 0.55 | 0.03 | 0.57 | 0.15 | 0.69 |
| Interest | 0.05 | 0.04 | 0.09 | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | 0.10 | 0.09 | 0.09 | 0.18 |
| Depreciation | 0.45 | 0.07 | 0.18 | 0.28 | 0.30 | 0.39 | 0.32 | 0.32 | 0.31 | 0.40 | 0.42 | 0.47 |
| Profit before tax | 1.43 | 0.74 | 0.33 | 2.01 | 0.42 | 1.86 | 1.04 | 1.34 | 0.86 | 2.23 | 1.34 | 2.28 |
| Tax % | 27.97% | 14.86% | 18.18% | 32.34% | 33.33% | 26.34% | 26.92% | 26.87% | 27.91% | 21.08% | 26.12% | 25.00% |
| Net Profit | 1.03 | 0.63 | 0.26 | 1.35 | 0.28 | 1.37 | 0.76 | 0.98 | 0.62 | 1.77 | 0.99 | 1.70 |
| EPS in Rs | 0.94 | 0.57 | 0.24 | 1.23 | 0.26 | 1.25 | 0.69 | 0.89 | 0.57 | 1.61 | 0.90 | 1.55 |
Last Updated: May 31, 2025, 6:15 am
Below is a detailed analysis of the quarterly data for DRA Consultants Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 12.34 Cr.. The value appears strong and on an upward trend. It has increased from 9.12 Cr. (Sep 2024) to 12.34 Cr., marking an increase of 3.22 Cr..
- For Expenses, as of Mar 2025, the value is 10.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.42 Cr. (Sep 2024) to 10.10 Cr., marking an increase of 2.68 Cr..
- For Operating Profit, as of Mar 2025, the value is 2.24 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Sep 2024) to 2.24 Cr., marking an increase of 0.54 Cr..
- For OPM %, as of Mar 2025, the value is 18.15%. The value appears to be declining and may need further review. It has decreased from 18.64% (Sep 2024) to 18.15%, marking a decrease of 0.49%.
- For Other Income, as of Mar 2025, the value is 0.69 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Sep 2024) to 0.69 Cr., marking an increase of 0.54 Cr..
- For Interest, as of Mar 2025, the value is 0.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Sep 2024) to 0.18 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Mar 2025, the value is 0.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.42 Cr. (Sep 2024) to 0.47 Cr., marking an increase of 0.05 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.28 Cr.. The value appears strong and on an upward trend. It has increased from 1.34 Cr. (Sep 2024) to 2.28 Cr., marking an increase of 0.94 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.12% (Sep 2024) to 25.00%, marking a decrease of 1.12%.
- For Net Profit, as of Mar 2025, the value is 1.70 Cr.. The value appears strong and on an upward trend. It has increased from 0.99 Cr. (Sep 2024) to 1.70 Cr., marking an increase of 0.71 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.55. The value appears strong and on an upward trend. It has increased from 0.90 (Sep 2024) to 1.55, marking an increase of 0.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:45 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.94 | 9.94 | 15.90 | 16.54 | 17.13 | 22.32 | 20.17 | 14.96 | 15.04 | 14.98 | 19.07 | 21.46 |
| Expenses | 7.67 | 7.57 | 12.12 | 12.97 | 12.87 | 18.03 | 17.65 | 12.65 | 12.42 | 12.41 | 15.68 | 17.52 |
| Operating Profit | 2.27 | 2.37 | 3.78 | 3.57 | 4.26 | 4.29 | 2.52 | 2.31 | 2.62 | 2.57 | 3.39 | 3.94 |
| OPM % | 22.84% | 23.84% | 23.77% | 21.58% | 24.87% | 19.22% | 12.49% | 15.44% | 17.42% | 17.16% | 17.78% | 18.36% |
| Other Income | 0.01 | 0.08 | 0.20 | 0.45 | 0.31 | 0.42 | 0.26 | 0.65 | 0.47 | 0.58 | 0.60 | 0.84 |
| Interest | 0.04 | 0.18 | 0.34 | 0.17 | 0.19 | 0.18 | 0.09 | 0.16 | 0.12 | 0.13 | 0.19 | 0.27 |
| Depreciation | 0.23 | 0.50 | 0.33 | 0.30 | 0.48 | 0.62 | 0.53 | 0.46 | 0.69 | 0.64 | 0.71 | 0.90 |
| Profit before tax | 2.01 | 1.77 | 3.31 | 3.55 | 3.90 | 3.91 | 2.16 | 2.34 | 2.28 | 2.38 | 3.09 | 3.61 |
| Tax % | 32.84% | 32.77% | 34.44% | 35.49% | 26.15% | -26.85% | 23.15% | 30.77% | 27.19% | 26.89% | 22.98% | 25.48% |
| Net Profit | 1.35 | 1.19 | 2.16 | 2.29 | 2.88 | 4.96 | 1.65 | 1.61 | 1.65 | 1.74 | 2.38 | 2.69 |
| EPS in Rs | 13,500.00 | 11,900.00 | 21,600.00 | 2.09 | 2.63 | 4.52 | 1.50 | 1.47 | 1.50 | 1.59 | 2.17 | 2.45 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.85% | 81.51% | 6.02% | 25.76% | 72.22% | -66.73% | -2.42% | 2.48% | 5.45% | 36.78% | 13.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | 93.36% | -75.49% | 19.75% | 46.46% | -138.96% | 64.31% | 4.91% | 2.97% | 31.33% | -23.76% |
DRA Consultants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 1% |
| 3 Years: | 13% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 20% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | -16% |
| 1 Year: | -66% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: September 10, 2025, 3:32 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 |
| Reserves | 6.44 | 7.57 | 10.10 | 4.39 | 7.26 | 10.13 | 11.78 | 13.39 | 15.04 | 16.78 | 19.16 | 21.85 |
| Borrowings | 0.19 | 0.13 | 0.00 | 0.15 | 0.52 | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 3.80 | 3.28 | 6.74 | 6.27 | 3.55 | 6.52 | 5.80 | 6.66 | 6.44 | 3.63 | 3.82 | 2.89 |
| Total Liabilities | 10.44 | 10.99 | 16.85 | 21.78 | 22.30 | 27.74 | 28.56 | 31.02 | 32.45 | 31.38 | 33.95 | 35.71 |
| Fixed Assets | 0.82 | 0.73 | 1.19 | 0.99 | 1.39 | 1.20 | 0.94 | 7.49 | 7.24 | 6.71 | 7.26 | 6.99 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.86 | 4.70 | 4.12 | 5.39 | 7.64 | 11.88 | 8.14 | 8.86 | 10.03 | 10.37 | 10.23 |
| Other Assets | 9.25 | 9.40 | 10.96 | 16.67 | 15.52 | 18.90 | 15.74 | 15.39 | 16.35 | 14.64 | 16.32 | 18.49 |
| Total Assets | 10.44 | 10.99 | 16.85 | 21.78 | 22.30 | 27.74 | 28.56 | 31.02 | 32.45 | 31.38 | 33.95 | 35.71 |
Below is a detailed analysis of the balance sheet data for DRA Consultants Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.97 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.97 Cr..
- For Reserves, as of Mar 2025, the value is 21.85 Cr.. The value appears strong and on an upward trend. It has increased from 19.16 Cr. (Mar 2024) to 21.85 Cr., marking an increase of 2.69 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 2.89 Cr.. The value appears to be improving (decreasing). It has decreased from 3.82 Cr. (Mar 2024) to 2.89 Cr., marking a decrease of 0.93 Cr..
- For Total Liabilities, as of Mar 2025, the value is 35.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 33.95 Cr. (Mar 2024) to 35.71 Cr., marking an increase of 1.76 Cr..
- For Fixed Assets, as of Mar 2025, the value is 6.99 Cr.. The value appears to be declining and may need further review. It has decreased from 7.26 Cr. (Mar 2024) to 6.99 Cr., marking a decrease of 0.27 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 10.23 Cr.. The value appears to be declining and may need further review. It has decreased from 10.37 Cr. (Mar 2024) to 10.23 Cr., marking a decrease of 0.14 Cr..
- For Other Assets, as of Mar 2025, the value is 18.49 Cr.. The value appears strong and on an upward trend. It has increased from 16.32 Cr. (Mar 2024) to 18.49 Cr., marking an increase of 2.17 Cr..
- For Total Assets, as of Mar 2025, the value is 35.71 Cr.. The value appears strong and on an upward trend. It has increased from 33.95 Cr. (Mar 2024) to 35.71 Cr., marking an increase of 1.76 Cr..
Notably, the Reserves (21.85 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.08 | 2.24 | 3.78 | 3.42 | 3.74 | 4.17 | 2.51 | 2.31 | 2.62 | 2.57 | 3.39 | 3.94 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 257.41 | 216.28 | 118.91 | 205.45 | 198.16 | 129.35 | 130.11 | 175.18 | 197.55 | 228.31 | 183.94 | 145.41 |
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 257.41 | 216.28 | 118.91 | 205.45 | 198.16 | 129.35 | 130.11 | 175.18 | 197.55 | 228.31 | 183.94 | 145.41 |
| Working Capital Days | 173.32 | 15.79 | 77.82 | 193.75 | 210.09 | 143.25 | 144.95 | 136.14 | 199.73 | 197.85 | 172.26 | 180.49 |
| ROCE % | 33.61% | 27.18% | 40.85% | 29.04% | 23.88% | 20.47% | 11.60% | 10.31% | 8.93% | 9.08% | 11.16% | 11.69% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.45 | 2.17 | 1.58 | 1.51 | 1.47 |
| Diluted EPS (Rs.) | 2.45 | 2.17 | 1.58 | 1.51 | 1.47 |
| Cash EPS (Rs.) | 3.27 | 2.82 | 2.17 | 2.14 | 1.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.92 | 27.47 | 25.30 | 23.71 | 22.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.92 | 27.47 | 25.30 | 23.71 | 22.21 |
| Revenue From Operations / Share (Rs.) | 19.56 | 17.89 | 13.71 | 13.79 | 13.81 |
| PBDIT / Share (Rs.) | 4.36 | 3.63 | 2.88 | 2.82 | 2.69 |
| PBIT / Share (Rs.) | 3.54 | 2.98 | 2.29 | 2.19 | 2.27 |
| PBT / Share (Rs.) | 3.29 | 2.81 | 2.17 | 2.07 | 2.13 |
| Net Profit / Share (Rs.) | 2.45 | 2.17 | 1.58 | 1.50 | 1.47 |
| PBDIT Margin (%) | 22.27 | 20.30 | 20.97 | 20.42 | 19.48 |
| PBIT Margin (%) | 18.08 | 16.67 | 16.69 | 15.84 | 16.45 |
| PBT Margin (%) | 16.82 | 15.73 | 15.79 | 15.03 | 15.42 |
| Net Profit Margin (%) | 12.54 | 12.12 | 11.53 | 10.91 | 10.66 |
| Return on Networth / Equity (%) | 8.20 | 7.90 | 6.25 | 6.34 | 6.62 |
| Return on Capital Employeed (%) | 11.82 | 10.86 | 9.04 | 9.21 | 10.22 |
| Return On Assets (%) | 7.54 | 7.01 | 5.54 | 5.09 | 5.20 |
| Asset Turnover Ratio (%) | 0.61 | 0.60 | 0.47 | 0.47 | 0.50 |
| Current Ratio (X) | 5.98 | 3.96 | 3.69 | 2.37 | 2.01 |
| Quick Ratio (X) | 5.98 | 3.96 | 3.69 | 2.37 | 2.01 |
| Interest Coverage Ratio (X) | 17.70 | 21.45 | 23.54 | 25.27 | 18.96 |
| Interest Coverage Ratio (Post Tax) (X) | 10.97 | 13.81 | 13.95 | 14.51 | 11.37 |
| Enterprise Value (Cr.) | 23.32 | 25.16 | 20.39 | 14.20 | 8.11 |
| EV / Net Operating Revenue (X) | 1.09 | 1.28 | 1.36 | 0.93 | 0.53 |
| EV / EBITDA (X) | 4.88 | 6.31 | 6.46 | 4.60 | 2.75 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.40 | 1.45 | 0.97 | 0.65 |
| Price / BV (X) | 0.83 | 0.91 | 0.78 | 0.56 | 0.40 |
| Price / Net Operating Revenue (X) | 1.27 | 1.40 | 1.45 | 0.97 | 0.65 |
| EarningsYield | 0.09 | 0.08 | 0.07 | 0.11 | 0.16 |
After reviewing the key financial ratios for DRA Consultants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 5. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 5. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.27. This value is within the healthy range. It has increased from 2.82 (Mar 24) to 3.27, marking an increase of 0.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.92. It has increased from 27.47 (Mar 24) to 29.92, marking an increase of 2.45.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.92. It has increased from 27.47 (Mar 24) to 29.92, marking an increase of 2.45.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.56. It has increased from 17.89 (Mar 24) to 19.56, marking an increase of 1.67.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.36. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 4.36, marking an increase of 0.73.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.54. This value is within the healthy range. It has increased from 2.98 (Mar 24) to 3.54, marking an increase of 0.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.29. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.29, marking an increase of 0.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For PBDIT Margin (%), as of Mar 25, the value is 22.27. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 22.27, marking an increase of 1.97.
- For PBIT Margin (%), as of Mar 25, the value is 18.08. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 18.08, marking an increase of 1.41.
- For PBT Margin (%), as of Mar 25, the value is 16.82. This value is within the healthy range. It has increased from 15.73 (Mar 24) to 16.82, marking an increase of 1.09.
- For Net Profit Margin (%), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 10. It has increased from 12.12 (Mar 24) to 12.54, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.20. This value is below the healthy minimum of 15. It has increased from 7.90 (Mar 24) to 8.20, marking an increase of 0.30.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 10.86 (Mar 24) to 11.82, marking an increase of 0.96.
- For Return On Assets (%), as of Mar 25, the value is 7.54. This value is within the healthy range. It has increased from 7.01 (Mar 24) to 7.54, marking an increase of 0.53.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.61. It has increased from 0.60 (Mar 24) to 0.61, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.98. This value exceeds the healthy maximum of 3. It has increased from 3.96 (Mar 24) to 5.98, marking an increase of 2.02.
- For Quick Ratio (X), as of Mar 25, the value is 5.98. This value exceeds the healthy maximum of 2. It has increased from 3.96 (Mar 24) to 5.98, marking an increase of 2.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.70. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 17.70, marking a decrease of 3.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.97. This value is within the healthy range. It has decreased from 13.81 (Mar 24) to 10.97, marking a decrease of 2.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.32. It has decreased from 25.16 (Mar 24) to 23.32, marking a decrease of 1.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.09, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 5. It has decreased from 6.31 (Mar 24) to 4.88, marking a decrease of 1.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.27, marking a decrease of 0.13.
- For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.83, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.27, marking a decrease of 0.13.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DRA Consultants Ltd:
- Net Profit Margin: 12.54%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.82% (Industry Average ROCE: 12.1%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.2% (Industry Average ROE: 10.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.97
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.29 (Industry average Stock P/E: 63.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.54%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Project Consultancy/Turnkey | Plot No 58, Nagpur Maharashtra 440005 | investors@dra.net.in www.dra.net.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh Chhaganlal Rathi | Chairman & Director |
| Mr. Aditya Dinesh Rathi | Managing Director |
| Mrs. Uma Dinesh Rathi | Executive Director |
| Ms. Siddhi Dinesh Rathi | Non Executive Director |
| Mr. Manavendra Jayapal | Independent Director |
| Mrs. Renuka Saurabh Borole | Independent Director |
FAQ
What is the intrinsic value of DRA Consultants Ltd?
DRA Consultants Ltd's intrinsic value (as of 14 October 2025) is 18.29 which is 14.93% lower the current market price of 21.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹23.6 Cr. market cap, FY2025-2026 high/low of 47.5/18.0, reserves of ₹21.85 Cr, and liabilities of 35.71 Cr.
What is the Market Cap of DRA Consultants Ltd?
The Market Cap of DRA Consultants Ltd is 23.6 Cr..
What is the current Stock Price of DRA Consultants Ltd as on 14 October 2025?
The current stock price of DRA Consultants Ltd as on 14 October 2025 is 21.5.
What is the High / Low of DRA Consultants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DRA Consultants Ltd stocks is 47.5/18.0.
What is the Stock P/E of DRA Consultants Ltd?
The Stock P/E of DRA Consultants Ltd is 9.29.
What is the Book Value of DRA Consultants Ltd?
The Book Value of DRA Consultants Ltd is 29.9.
What is the Dividend Yield of DRA Consultants Ltd?
The Dividend Yield of DRA Consultants Ltd is 0.00 %.
What is the ROCE of DRA Consultants Ltd?
The ROCE of DRA Consultants Ltd is 11.7 %.
What is the ROE of DRA Consultants Ltd?
The ROE of DRA Consultants Ltd is 8.07 %.
What is the Face Value of DRA Consultants Ltd?
The Face Value of DRA Consultants Ltd is 10.0.